Novarus (Novi) Revenue Q4, Full Year Fy24

Swiss Giant Giant Giants Novirts In the fourth quarter of the fourth quarter, he was closed with protects protected sales, but with its own guidelines for more than a whole year.

Fourth-quarter of the networks of Loseg Prome permanently, 16% permanently 16% permanent information on 12.795 billion).

The total structure of the Colonial Procedure is expected to $ 4.23 billion by $ 4.86 billion.

Net sale was 20% of the $ 50.32 billion of $ 50.32 billion, $ 50.47 billion, $ 50.32 billion. The main income of a full year is 22% to $ 19.5 $ 19.5 to $ 19.5 and predict less than $ 17.5 billion billion.

The company is mainly driven sales growth mainly driven heart-abuse drug addict and arthritis medicine.

Novartis Holded for the third-year-old workplace of workplace, and discover the percentage of the “high-young people” in advance.

The capital city In 2023, during proveing ​​a strategic system of business, they marked the main signal.

“In the same age, our human resources and major work-based currency in history, novadis are 12% of the cycles in the history of 12% of the civilian currency in history.

By 2025 we look forward to continuing solid cavities and continue to keep on the guidance of our salvation.

In the future, the interruption of the versusha and the company said the development plugs that is capable of driving in a long time.

In addition, the company orders directions for 2025, including the forecast to high units and the lowest digits of the majority of two digits “.